Britain and France invest €1.5B in Eutelsat to rival SpaceX Starlink
The move aims to counter SpaceX's Starlink dominance and enhance sovereign satellite communications.
The French government is set to become Eutelsat's largest shareholder with a €750 million injection, raising its stake to 29.65%. Britain's investment ensures it retains its 10.89% stake and avoids dilution from France's earlier recapitalisation plan.
British Science and Technology Minister Peter Kyle highlighted the strategic importance of resilient satellite connectivity for national security.
'As our adversaries increasingly use space technologies to harm us, resilient satellite connectivity has become essential to our continent's security,' he said.
Eutelsat's shares surged 10% in early Paris trading following the announcement. The company, which operates 34 geostationary satellites and over 600 low Earth orbit satellites, is the second-largest constellation provider after Starlink.
The deal could also pave the way for Britain's participation in the EU's IRIS² satellite project, where Eutelsat is a key contractor. Britain initially invested in Eutelsat's subsidiary OneWeb in 2020 as part of a $1 billion bailout before the merger with Eutelsat last year.
France's President Emmanuel Macron thanked Britain for its contribution during his state visit. The total recapitalisation now stands at €1.5 billion, reinforcing Europe's push for independent space infrastructure amid rising geopolitical tensions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
an hour ago
- The Star
Asian markets mostly rise on lingering trade deal optimism
HONG KONG: Most Asian markets rose Monday (July 14) as investors digested Donald Trump's latest trade war salvos that saw him threaten to hit the European Union and Mexico with 30 per cent tariffs. The US president's outburst came after a series of announcements last week including warnings of 50 per cent levies on copper and Brazilian goods, 35 per cent on Canadian goods, and a possible 200 per cent charge on pharmaceuticals. While observers warn the measures could deal a hefty blow to the global economy, investors are largely optimistic that governments will hammer out agreements before the White House's August 1 deadline. In announcing his latest measures on Saturday, Trump cited Mexico's role in illicit drugs flowing into the United States and a trade imbalance with the European Union. The move threw months of painstaking talks with Brussels into disarray. European Commission chief Ursula von der Leyen has insisted the bloc still wants to reach an accord - and on Sunday delayed retaliation over separate US duties on steel and aluminium as a sign of goodwill. EU officials threatened in May to impose tariffs on US goods worth around 100 billion euros (US$117 billion), including cars and planes, if talks fail. French President Emmanuel Macron backed efforts to reach an agreement that "reflects the respect that trade partners such as the European Union and the United States owe each other". But he urged the bloc to "step up the preparation of credible countermeasures" if the two sides fail to reach an agreement. Analysts also pointed out that the levies against Mexico and Canada come even after Trump agreed a trade deal with the two during his first administration. Still, Asian investors brushed off Friday's losses in New York and Europe, remaining hopeful that governments will strike deals with Washington and avoid the worst of the tariffs. Hong Kong, Shanghai, Sydney, Seoul, Singapore, Manila and Jakarta all rose, with Tokyo, Wellington and Taipei edging down. Bitcoin hit a new record high of US$119,490. "It is hard to say whether the muted market response over the week is best characterised by resilience or complacency," said National Australia Bank's Taylor Nugent. "But it is difficult to price the array of headlines purportedly defining where tariffs will sit from 1 August when negotiations are ongoing." Traders are also keeping a nervous eye on the Federal Reserve as Trump continues to berate boss Jerome Powell for not cutting interest rates soon enough, saying Sunday "I hope he quits", and adding "He should quit". Reports also said the president's allies were targeting the Fed chief over his handling of an expensive renovation at the bank's headquarters, with some suggesting they were building a case to have him removed over it. However, strategists warned that such a move would bring the independence of the central bank into question and send US Treasury yields soaring and the dollar plunging. - AFP
The Star
an hour ago
- The Star
UK agrees to deal with Vietnam to remove pharmaceutical trade barriers
Vietnam will hasten the registration of new medicines and vaccines, while recognising approvals from more regulators. - Reuters LONDON: Britain said it would strike an agreement with Vietnam to make it easier for pharmaceutical firms to sell UK-made medicines in the nation, under a new trade strategy that emphasises quick, industry-specific deals. Britain launched the new strategy last month, promising a nimbler approach compared to the emphasis it placed on full-fledged free trade agreements following its departure from the European Union. Vietnam will hasten the registration of new medicines and vaccines, while recognising approvals from more regulators, including Britain's Medicines and Healthcare products Regulatory Agency, the British government told Reuters in a statement. The deal is expected to be confirmed later on Monday. "The removal of pharmaceutical barriers with one of our closest trading partners in Asia is a boost for the UK pharmaceutical industry and proof our Industrial and Trade Strategies are already delivering," British trade minister Douglas Alexander said. The deal could be worth 250 million pounds (US$337 million) to the British pharmaceutical sector over the next five years, the government added. The UK-Vietnamese Joint Economic and Trade Committee will meet in London on Monday (July 14) and also discuss financial services and renewable energy. Britain has taken a tougher line on some other sectors, however, with steel imports from Vietnam set to be restricted under a new quota regime. Life sciences, including pharmaceuticals, are a priority sector under Britain's new industrial strategy, which was also launched last month. However, that plan has been delayed by a dispute over drug pricing with the British pharmaceutical sector, which says the government needs to value medicines more fairly and adjust the payments they make back to the health service. - Reuters
The Star
an hour ago
- The Star
Ringgit rises as US plans new tariffs
KUALA LUMPUR: The ringgit opened higher against the US dollar on Monday, lifted by concerns over Washington's plan to impose tariffs on three major trading partners from Aug 1, 2025. Over the weekend, United States President Donald Trump announced plans to impose a 30 per cent tariff on goods from the European Union and Mexico, and a 35 per cent tariff on Canadian products. At 8 am, the ringgit strengthened to 4.2405/2635 against the greenback, compared with Friday's close of 4.2475/2525. Bank Muamalat Malaysia Bhd chief economist Dr Mohd Afzanizam Abdul Rashid said the US had weaponised tariffs to gain economic advantage. "Clearly, the tariff policy instrument has been weaponised by the US to address economic imbalances. "This means downside risks to global growth remain elevated, while the risk of higher inflation especially in the US, is becoming more apparent, complicating the Federal Reserve's decision-making on rate cuts,' he told Bernama. Mohd Afzanizam added that the ringgit is expected to remain within a narrow range of RM4.24 to RM4.25 amid ongoing global uncertainties. At the open, the ringgit was higher against a basket of major currencies. It advanced against the Japanese yen to 2.8792/8950 from 2.8893/8929, strengthened against the British pound to 5.7234/7544 from 5.7524/7592, and gained versus the euro to 4.9546/9815 from 4.9679/9737 previously. The local note was also firmer against most ASEAN currencies, except the Thai baht. It rose vis-a-vis the Singapore dollar to 3.3119/3303 from 3.3186/3228, edged up against the Indonesian rupiah to 261.4/263.0 from 261.8/262.3, and appreciated versus the Philippine peso to 7.51/7.55 from 7.52/7.53. However, it slipped against the Thai baht to 13.0916/1711 from 13.0668/0886 at Friday's close. - Bernama
